The benchmark indices kicked off the March series on a higher note with the Nifty50 reclaiming its crucial 10,400-mark, tracking positive trend seen in Asian markets. However, the broader momentum remained tepid.
At 9:18 am, the S&P BSE Sensex was trading at 33,928, up 108.73 points, while the broader Nifty50 was ruling at 10,419, up 37 points.
In the broader market, the BSE Midcap and the BSE Smallcap indices were up 0.5 per cent each.
Market breadth, indicating the overall health of the market, turned positive. On the BSE, 888 stocks rose, 321 stocks declined, while 36 stocks remained unchanged.
Pharma stocks hogged the limelight with the Nifty Pharma index (up 1.4 per cent) gaining the most. Sun Pharma, Aurobindo Pharma and Cipla were the top gainers on the index, and rallied up to 2 per cent on the NSE.
Asian shares rebounded on Friday as comments from a Federal Reserve official eased worries that the central bank might raise rates more aggressively this year.
MSCI’s broadest index of Asia-Pacific shares outside Japan climbed 0.4 per cent, but was still on track to end the week barely changed.
Australian and New Zealand shares were each up 0.5 per cent while Japan's Nikkei edged 0.3 per cent higher and South Korea's KOSPI index rose 1 per cent.
On Wall Street, the Dow added 0.7 per cent, the S&P 500 ended a tad firmer while the Nasdaq lost 0.11 per cent.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Anil Singhvi: Unless coronavirus vaccine comes, things will not improve significantly
EXPLAINED! Anil Singhvi on his campaign to protect investors and save their hard-earned money; reveals market strategy going forward
Share market today: Abbott India, Aavas Financiers share prices rise, fight off negative Sensex, Nifty trend
Anil Singhvi’s Strategy March 30: 8,300-8,400 is Next Support Zone on Nifty
Stocks in Focus on March 30: MCX, Delta Corp to Lupin; here are the 5 Newsmakers of the Day